[EN] Type 1 diabetes is an autoimmune condition characterised by a pancreatic insulin secretion deficit, resulting in high blood glucose concentrations, which can lead to micro- and macrovascular complications. Type 1 ...
Beneyto, Aleix; Bertachi, Arthur; Bondía Company, Jorge; Vehí, Josep(Institute of Electrical and Electronics Engineers, 2020-03)
[EN] The artificial pancreas (AP) system or closed-loop blood glucose (BG) regulation is a technological advancement that aims to relieve diabetic subjects from their current decision-making burden while tightening their ...
[EN] Background:
Estimating the rate of glucose appearance (Ra) after ingestion of a mixed meal may be highly valuable in diabetes management. The gold standard technique for estimating Ra is the use of a multitracer oral ...
Barceló-Rico, Fátima; Diez, José-Luís; Rossetti, Paolo; Vehi, Josep; Bondía Company, Jorge(Institute of Electrical and Electronics Engineers, 2013)
[EN] Minimally or noninvasive continuous glucose monitors estimate plasma glucose from compartments alternative to blood, and may revolutionize the management of diabetes. However, the accuracy of current devices is still ...
[EN] Background: Postprandial (PP) control remains a challenge for closed-loop (CL) systems. Few studies with inconsistent results have systematically investigated the PP period.
Objective: To compare a new CL algorithm ...
[ES] La Diabetes Mellitus Tipo 1 (DMT1) es una de las enfermedades actuales más dañinas que afectan a personas de cualquier edad incluyendo niños desde el nacimiento. Las inyecciones de insulina exógena siguen siendo el ...
Vanderhaegen, Alec(Universitat Politècnica de València, 2019-10-24)
[ES] El propósito de esta tesis de maestría es desarrollar un prototipo de un wearable útil para su integración en un páncreas artificial (sistema de control automático de glucosa) para adultos con diabetes tipo 1. Este ...
Herrero, P.; Bondía Company, Jorge; Adewuji, O.; Pesl, P.; El-Sharkawy, M.; Reddy, M.; Toumazou, C.; Oliver, N.; Georgiou, P.(Elsevier, 2017)
[EN] Background and Objective: Current prototypes of closed-loop systems for glucose control in type 1 diabetes mellitus, also referred to as artificial pancreas systems, require a pre-meal insulin bolus to compensate for ...
Carmona Vila, Jahel(Universitat Politècnica de València, 2019-10-28)
[ES] En este proyecto se diseñan, desarrollan y despliegan un conjunto de servicios en la nube, que permiten el desarrollo de actividades de interacción personarobot en un robot humanoide NAO, desacoplando el control de ...
[EN] Background: An artificial pancreas with insulin and glucagon delivery has the potential to reduce the risk of hypo- and hyperglycemia in people with type 1 diabetes. However, a maximum dose of glucagon of 1 mg/d is ...
Continuous glucose monitors can measure interstitial glucose concentration in real time for closed-loop glucose control systems, known as artificial pancreas. These control systems use an insulin feedback to maintain plasma ...
Revert Tomás, Ana; Garelli, Fabricio; Picó, Jesús; De Battista, Hernan; Rossetti, Paolo; Bondía Company, Jorge(Institute of Electrical and Electronics Engineers, 2013-08)
[EN] The artificial pancreas aims at the automatic deliv-ery of insulin for glycemic control in patients with type 1 diabetes, i.e., closed-loop glucose control. One of the challenges of the arti-ficial pancreas is to avoid ...
[EN] The artificial pancreas (AP) system is designed to regulate blood glucose in subjects with type 1 diabetes using a continuous glucose monitor informed controller that adjusts insulin infusion via an insulin pump. ...